Inaugural RespiV PlexPlus®* product showcases advantages SpeeDx unveils a new innovative spin on qPCR technology that doubles the standard target output. Without requiring specialized equipment, the new PlexPlus® technology does all...
EntericPlex* products Sharpen Your Focus SpeeDx have released a suite of gastroenteritis panels, the three EntericPlex RUO assays, each with up to 5 targets in a single-well multiplexed qPCR/NAAT assay⎯differing from...
Upfront diagnosis. Combat seasonal testing surges with ease PlexPCR® Flu/RSV/SARS-CoV-2 detects Influenza, Respiratory Syncytial Virus and SARS-CoV-2 virus in a single-well multiplex qPCR test. Prompt identification of these viral infections can...
SpeeDx Pty. Ltd., have released a new Research Use Only (RUO) product providing an exciting expansion of their research offering. CT/GC/TV/MGPlex* simultaneously detects Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), Trichomonas...
Adjunct Professor Alison Todd, AM FTSE PhD, a distinguished figure in the field of medical research and tertiary education, has been recognized for her exceptional contributions and honoured as a...
Alison Todd and Elisa Mokany are developing diagnostic tests that can detect antimicrobial resistance at their award-winning Sydney biotechnology company SpeeDx. Just over a decade ago, biotechnology researchers Alison Todd and...
Partnership with Biosapientia expands SpeeDx product availability in France SYDNEY, AUSTRALIA – (May 17, 2023). SpeeDx have announced signing a new distribution partner, further extending access for customers to market leading...
EXCLUSIVE By JARED LYNCH REPORTER @jaredm_lynch APRIL 10, 2023 A diagnostics company backed by mining billionaire Andrew Forrest is donating thousands of PCR tests to Papua New Guinea to avoid Australia’s closest neighbour becoming a...
The Age Melissa Cunningham February 25, 2023 — 7.30pm Sexual health physicians are pushing for PCR testing for syphilis to be used widely amid a worsening epidemic in Melbourne that has led to...
Funds will accelerate technology development to increase actionable patient results per test SYDNEY Australia 28 February 2023, SpeeDx Pty. Ltd., a developer of transformative molecular diagnostic solutions, has today announced...